When it comes to complex diseases, one size doesn’t fit all. In this #DrawnToScience episode, scientist Abbas Walji breaks down how matching the right modality, or type of molecule, to the right target is shaping the pursuit of potential new medicines and vaccines. #MerckProud
Understanding Triple-Negative Breast Cancer (TNBC) #MerckProud bit.ly/4yDOuiu
The Elkton, VA facility has been part of our company’s story for 85 years. You know it’s a special place to work when multiple generations of families have helped carry its legacy forward. #MerckProud bit.ly/4wJtzsz
The Elkton, VA facility has been part of our company’s story for 85 years. You know it’s a special place to work when multiple generations of families have helped carry its legacy forward. #MerckProud bit.ly/4vtBOYz
I’m proud to work alongside colleagues who are advancing cardio-pulmonary disease research at Merck with a goal of helping to address the burden of these diseases on patients. Learn more about our efforts: go.merck.com/~gjs #MerckProud
Merck has a long history in cardiovascular (CV) research. I’m proud to support my colleagues as they share important findings at #ACC26 that reinforce our commitment to help address the CV epidemic. Learn more: go.merck.com/~gjs #MerckProud







